EDGAR Filing Documents for 0000000000-17-026091

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-17-026091

Filing Date

2017-07-25

Accepted

2017-07-25 14:48:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	25309
	Complete submission text file	0000000000-17-026091.txt		35723

Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087

Rasna Therapeutics Inc. (Filed for) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0331
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations